In summary, the clinical features, MM-COAST scores, histopathological findings (such as RRF and COX- fibers), and GDF15 levels in Group I supported a higher likelihood of a PMD diagnosis as compared to Groups II and III. The gene discussed is GDF15; the disease is Miyoshi myopathy.